Vera Krane

12.0k total citations · 1 hit paper
85 papers, 4.6k citations indexed

About

Vera Krane is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Vera Krane has authored 85 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Nephrology, 37 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Surgery. Recurrent topics in Vera Krane's work include Dialysis and Renal Disease Management (31 papers), Lipoproteins and Cardiovascular Health (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). Vera Krane is often cited by papers focused on Dialysis and Renal Disease Management (31 papers), Lipoproteins and Cardiovascular Health (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). Vera Krane collaborates with scholars based in Germany, Austria and Netherlands. Vera Krane's co-authors include Christoph Wanner, Winfried März, Eberhard Ritz, G. Ruf, Manfred Olschewski, Johannes F.E. Mann, Christiane Drechsler, Stefan Pilz, Christoph Wanner and Andreas Tomaschitz and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Vera Krane

82 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

2005 1.8k citations Christoph Wanner, Vera Krane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vera Krane Germany	31	2.0k	1.7k	1.3k	1.1k	533	85	4.6k
Aimun Ahmed United Kingdom	8	2.4k 1.2×	1.2k 0.7×	3.5k 2.8×	1.3k 1.2×	1.1k 2.0×	19	7.0k
Hallvard Holdaas Norway	44	1.9k 0.9×	3.5k 2.0×	899 0.7×	972 0.9×	1.5k 2.8×	215	7.6k
Christiane Drechsler Germany	42	1.6k 0.8×	1.2k 0.7×	1.1k 0.9×	1.3k 1.1×	582 1.1×	124	5.3k
Marije van der Velde Netherlands	8	3.3k 1.7×	736 0.4×	1.7k 1.3×	968 0.9×	733 1.4×	9	5.4k
Roberto Minutolo Italy	45	3.0k 1.5×	781 0.5×	1.9k 1.5×	940 0.8×	758 1.4×	187	5.6k
Patrick S. Parfrey Canada	21	4.7k 2.4×	1.2k 0.7×	2.4k 1.9×	703 0.6×	1.3k 2.4×	44	7.8k
Marc A. Pfeffer United States	19	2.9k 1.5×	794 0.5×	2.3k 1.8×	551 0.5×	739 1.4×	39	6.5k
Tara I. Chang United States	34	1.9k 1.0×	1.3k 0.8×	2.6k 2.1×	677 0.6×	911 1.7×	132	5.2k
Ellie Kelepouris United States	13	2.3k 1.2×	803 0.5×	1.9k 1.5×	459 0.4×	791 1.5×	34	4.5k
Cassianne Robinson‐Cohen United States	38	1.7k 0.9×	672 0.4×	666 0.5×	544 0.5×	322 0.6×	105	4.3k

Countries citing papers authored by Vera Krane

Since Specialization

Citations

This map shows the geographic impact of Vera Krane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Krane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Krane more than expected).

Fields of papers citing papers by Vera Krane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Krane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Krane. The network helps show where Vera Krane may publish in the future.

Co-authorship network of co-authors of Vera Krane

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Krane. A scholar is included among the top collaborators of Vera Krane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Krane. Vera Krane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marx, Nikolaus, Christoph Wanner, Joachim Jankowski, et al.. (2023). Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study. Clinical Kidney Journal. 16(10). 1612–1621.

Malzahn, Uwe, J. LEWI DONHAUSER, Dan Liu, et al.. (2020). Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients. Cardiovascular Ultrasound. 18(1). 39–39. 7 indexed citations

Keller, Till, Christoph Wanner, Vera Krane, et al.. (2018). Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis. American Journal of Kidney Diseases. 71(6). 822–830. 16 indexed citations

Krane, Vera, et al.. (2016). Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis. Kidney International. 89(6). 1380–1387. 28 indexed citations

Schneider, Markus P., Sílvia de Oliveira Hübner, Stephanie Titze, et al.. (2015). Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates. Kidney International. 88(6). 1411–1418. 18 indexed citations

Rahimi, Kazem, Neeraj Bhala, Pieter W. Kamphuisen, et al.. (2012). Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials. PLoS Medicine. 9(9). e1001310–e1001310. 77 indexed citations

Drechsler, Christiane, Andreas Meinitzer, Stefan Pilz, et al.. (2011). Homoarginine, Heart Failure, and Sudden Cardiac Death in Haemodialysis Patients. European Journal of Heart Failure. 13(8). 852–859. 61 indexed citations

Rahimi, Kazem, Jonathan Emberson, Paul McGale, et al.. (2011). Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 342(mar16 2). d1250–d1250. 92 indexed citations

Wanner, Christoph & Vera Krane. (2011). Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus. Kidney & Blood Pressure Research. 34(4). 209–217. 12 indexed citations

10.

Pilz, Stefan, Andreas Meinitzer, Christiane Drechsler, et al.. (2011). Low homoarginine concentration is a novel risk factor for heart disease. Heart. 97(15). 1222–1227. 89 indexed citations

11.

Schneider, Andreas, Christiane Drechsler, Vera Krane, et al.. (2011). The Effect of High-Flux Hemodialysis on Hemoglobin Concentrations in Patients with CKD. Clinical Journal of the American Society of Nephrology. 7(1). 52–59. 18 indexed citations

12.

Meinitzer, Andreas, Christiane Drechsler, Andreas Tomaschitz, et al.. (2011). Homoarginin: ein neuer kardiovaskulärer Risikomarker bei Dialysepatienten / Homoarginine: a new cardiovascular risk marker in hemodialysis patients. LaboratoriumsMedizin. 35(3). 153–159. 6 indexed citations

13.

Krane, Vera, et al.. (2010). Antibodies to Platelet Factor 4–Heparin Complex and Outcome in Hemodialysis Patients with Diabetes. Clinical Journal of the American Society of Nephrology. 5(5). 874–881. 9 indexed citations

14.

Krane, Vera, et al.. (2008). Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney International. 74(11). 1461–1467. 63 indexed citations

15.

Breunig, Frank, Frank Weidemann, Meinrad Beer, et al.. (2003). Fabry disease: Diagnosis and treatment. Kidney International. 63(84). S181–S185. 30 indexed citations

16.

Wanner, Christoph & Vera Krane. (2003). Non-high-density lipoprotein cholesterol: A target of lipid-lowering in dialysis patients. American Journal of Kidney Diseases. 41(3). S72–S75. 15 indexed citations

17.

Krane, Vera & Christoph Wanner. (2002). The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease. Nephrology Dialysis Transplantation. 17(suppl 11). 23–27. 12 indexed citations

18.

Wanner, Christoph & Vera Krane. (2002). Uremia-Specific Alterations in Lipid Metabolism. Blood Purification. 20(5). 451–453. 22 indexed citations

19.

Krane, Vera & Christoph Wanner. (2001). Cardiovascular Disease and Predisposing Factors in Chronic Renal Failure. Journal of clinical and basic cardiology. 4(2). 97–100. 6 indexed citations

20.

Wanner, Christoph, et al.. (1999). Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Kidney International. 56. S222–S226. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact